Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis
Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan...
Gespeichert in:
Veröffentlicht in: | Molecular metabolism (Germany) 2019-01, Vol.19, p.97-106 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 106 |
---|---|
container_issue | |
container_start_page | 97 |
container_title | Molecular metabolism (Germany) |
container_volume | 19 |
creator | Wolff, G. Taranko, A.E. Meln, I. Weinmann, J. Sijmonsma, T. Lerch, S. Heide, D. Billeter, A.T. Tews, D. Krunic, D. Fischer-Posovszky, P. Müller-Stich, B.P. Herzig, S. Grimm, D. Heikenwälder, M. Kao, W.W. Vegiopoulos, A. |
description | Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan Lumican in metabolically driven nonalcoholic fatty liver disease sparks an interest in further understanding its role in diet-induced obesity and metabolic complications.
Whole body ablation of Lumican (Lum−/−) gene and adeno-associated virus-mediated over-expression were used in combination with control or high fat diet to assess energy balance, glucose homeostasis as well as adipose tissue health and remodeling.
Lumican was found to be particularly enriched in the stromal cells isolated from murine gonadal white adipose tissue. Likewise murine and human visceral fat showed a robust increase in Lumican as compared to fat from the subcutaneous depot. Lumican null female mice exhibited moderately increased fat mass, decreased insulin sensitivity and increased liver triglycerides in a diet-dependent manner. These changes coincided with inflammation in adipose tissue and no overt effects in adipose expandability, i.e. adipocyte formation and hypertrophy. Lumican over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.
These data indicate that Lumican may represent a functional link between the extracellular matrix, glucose homeostasis, and features of the metabolic syndrome.
•The extracellular matrix proteoglycan Lumican (Lum) is particularly enriched in stromal cells within white adipose tissue.•Visceral fat from obese patients displays increased levels of Lum compared to subcutaneous fat.•Lum-Ko female mice exhibit decreased insulin sensitivity and increased triglycerides upon high-fat diet (HFD) feeding.•Lum-Ko female mice on HFD have increased inflammation in white fat in the absence of overt effects on adipocyte formation.•· Lum over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance. |
doi_str_mv | 10.1016/j.molmet.2018.10.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6323191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2212877818308378</els_id><sourcerecordid>2132276802</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-3157c41da7fc528337004fbc7de6c761d3889d04c7fd9f73c9c9e6997b99f1073</originalsourceid><addsrcrecordid>eNp9UUtvEzEQtlARrUr_AUI-ctnUj429viChFmilSFzgbDn2OHHYtYPtrZp_zy4pfVw6lxnN4_tm5kPoAyULSqi43C2G1A9QF4zQbkotCJFv0BljlDWdlN3Js_gUXZSyI5N1QoglfYdOOWmJkoSfod_XAWrjYA_RQazYj9HWkCJOHtctYLiv2Vjo-7E3GQ-m5nCP9zlVSJv-YE3Eq3EIsw_TzBpKqAdsosObfrSpAN6mAVKppoTyHr31pi9w8eDP0a9vX39e3TSrH99vr76sGtsKXhtOl9K21Bnp7ZJ1nEtCWr-20oGwUlDHu0450lrpnfKSW2UVCKXkWilPieTn6PMRdz-uB3B2uiubXu9zGEw-6GSCflmJYas36U4LzjhVdAL49ACQ058RStVDKPMTTIQ0Fs0oZ0yKjrCptT222pxKyeAfaSjRs1R6p49S6VmqOUv-rfjx-YqPQ_-FeboBpkfdBci62ADRggsZbNUuhdcZ_gJJkKom</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2132276802</pqid></control><display><type>article</type><title>Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wolff, G. ; Taranko, A.E. ; Meln, I. ; Weinmann, J. ; Sijmonsma, T. ; Lerch, S. ; Heide, D. ; Billeter, A.T. ; Tews, D. ; Krunic, D. ; Fischer-Posovszky, P. ; Müller-Stich, B.P. ; Herzig, S. ; Grimm, D. ; Heikenwälder, M. ; Kao, W.W. ; Vegiopoulos, A.</creator><creatorcontrib>Wolff, G. ; Taranko, A.E. ; Meln, I. ; Weinmann, J. ; Sijmonsma, T. ; Lerch, S. ; Heide, D. ; Billeter, A.T. ; Tews, D. ; Krunic, D. ; Fischer-Posovszky, P. ; Müller-Stich, B.P. ; Herzig, S. ; Grimm, D. ; Heikenwälder, M. ; Kao, W.W. ; Vegiopoulos, A.</creatorcontrib><description>Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan Lumican in metabolically driven nonalcoholic fatty liver disease sparks an interest in further understanding its role in diet-induced obesity and metabolic complications.
Whole body ablation of Lumican (Lum−/−) gene and adeno-associated virus-mediated over-expression were used in combination with control or high fat diet to assess energy balance, glucose homeostasis as well as adipose tissue health and remodeling.
Lumican was found to be particularly enriched in the stromal cells isolated from murine gonadal white adipose tissue. Likewise murine and human visceral fat showed a robust increase in Lumican as compared to fat from the subcutaneous depot. Lumican null female mice exhibited moderately increased fat mass, decreased insulin sensitivity and increased liver triglycerides in a diet-dependent manner. These changes coincided with inflammation in adipose tissue and no overt effects in adipose expandability, i.e. adipocyte formation and hypertrophy. Lumican over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.
These data indicate that Lumican may represent a functional link between the extracellular matrix, glucose homeostasis, and features of the metabolic syndrome.
•The extracellular matrix proteoglycan Lumican (Lum) is particularly enriched in stromal cells within white adipose tissue.•Visceral fat from obese patients displays increased levels of Lum compared to subcutaneous fat.•Lum-Ko female mice exhibit decreased insulin sensitivity and increased triglycerides upon high-fat diet (HFD) feeding.•Lum-Ko female mice on HFD have increased inflammation in white fat in the absence of overt effects on adipocyte formation.•· Lum over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.</description><identifier>ISSN: 2212-8778</identifier><identifier>EISSN: 2212-8778</identifier><identifier>DOI: 10.1016/j.molmet.2018.10.007</identifier><identifier>PMID: 30409703</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Adipocytes - metabolism ; Adipose ; Adipose Tissue - metabolism ; Adipose Tissue, White - metabolism ; Adiposity - drug effects ; Adult ; Animals ; Brief Communication ; Diet, High-Fat ; ECM ; Extracellular Matrix - metabolism ; Female ; Glucose - metabolism ; Homeostasis ; Humans ; Inflammation ; Insulin ; Insulin Resistance ; Intra-Abdominal Fat - metabolism ; Liver - metabolism ; Lumican ; Lumican - genetics ; Lumican - metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Middle Aged ; Non-alcoholic Fatty Liver Disease - metabolism ; Obesity ; Obesity - metabolism ; Proteoglycans - metabolism</subject><ispartof>Molecular metabolism (Germany), 2019-01, Vol.19, p.97-106</ispartof><rights>2018 The Authors</rights><rights>Copyright © 2018 The Authors. Published by Elsevier GmbH.. All rights reserved.</rights><rights>2018 The Authors 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-3157c41da7fc528337004fbc7de6c761d3889d04c7fd9f73c9c9e6997b99f1073</citedby><cites>FETCH-LOGICAL-c463t-3157c41da7fc528337004fbc7de6c761d3889d04c7fd9f73c9c9e6997b99f1073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323191/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323191/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30409703$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolff, G.</creatorcontrib><creatorcontrib>Taranko, A.E.</creatorcontrib><creatorcontrib>Meln, I.</creatorcontrib><creatorcontrib>Weinmann, J.</creatorcontrib><creatorcontrib>Sijmonsma, T.</creatorcontrib><creatorcontrib>Lerch, S.</creatorcontrib><creatorcontrib>Heide, D.</creatorcontrib><creatorcontrib>Billeter, A.T.</creatorcontrib><creatorcontrib>Tews, D.</creatorcontrib><creatorcontrib>Krunic, D.</creatorcontrib><creatorcontrib>Fischer-Posovszky, P.</creatorcontrib><creatorcontrib>Müller-Stich, B.P.</creatorcontrib><creatorcontrib>Herzig, S.</creatorcontrib><creatorcontrib>Grimm, D.</creatorcontrib><creatorcontrib>Heikenwälder, M.</creatorcontrib><creatorcontrib>Kao, W.W.</creatorcontrib><creatorcontrib>Vegiopoulos, A.</creatorcontrib><title>Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis</title><title>Molecular metabolism (Germany)</title><addtitle>Mol Metab</addtitle><description>Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan Lumican in metabolically driven nonalcoholic fatty liver disease sparks an interest in further understanding its role in diet-induced obesity and metabolic complications.
Whole body ablation of Lumican (Lum−/−) gene and adeno-associated virus-mediated over-expression were used in combination with control or high fat diet to assess energy balance, glucose homeostasis as well as adipose tissue health and remodeling.
Lumican was found to be particularly enriched in the stromal cells isolated from murine gonadal white adipose tissue. Likewise murine and human visceral fat showed a robust increase in Lumican as compared to fat from the subcutaneous depot. Lumican null female mice exhibited moderately increased fat mass, decreased insulin sensitivity and increased liver triglycerides in a diet-dependent manner. These changes coincided with inflammation in adipose tissue and no overt effects in adipose expandability, i.e. adipocyte formation and hypertrophy. Lumican over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.
These data indicate that Lumican may represent a functional link between the extracellular matrix, glucose homeostasis, and features of the metabolic syndrome.
•The extracellular matrix proteoglycan Lumican (Lum) is particularly enriched in stromal cells within white adipose tissue.•Visceral fat from obese patients displays increased levels of Lum compared to subcutaneous fat.•Lum-Ko female mice exhibit decreased insulin sensitivity and increased triglycerides upon high-fat diet (HFD) feeding.•Lum-Ko female mice on HFD have increased inflammation in white fat in the absence of overt effects on adipocyte formation.•· Lum over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.</description><subject>Adipocytes - metabolism</subject><subject>Adipose</subject><subject>Adipose Tissue - metabolism</subject><subject>Adipose Tissue, White - metabolism</subject><subject>Adiposity - drug effects</subject><subject>Adult</subject><subject>Animals</subject><subject>Brief Communication</subject><subject>Diet, High-Fat</subject><subject>ECM</subject><subject>Extracellular Matrix - metabolism</subject><subject>Female</subject><subject>Glucose - metabolism</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Intra-Abdominal Fat - metabolism</subject><subject>Liver - metabolism</subject><subject>Lumican</subject><subject>Lumican - genetics</subject><subject>Lumican - metabolism</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Middle Aged</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Obesity</subject><subject>Obesity - metabolism</subject><subject>Proteoglycans - metabolism</subject><issn>2212-8778</issn><issn>2212-8778</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UUtvEzEQtlARrUr_AUI-ctnUj429viChFmilSFzgbDn2OHHYtYPtrZp_zy4pfVw6lxnN4_tm5kPoAyULSqi43C2G1A9QF4zQbkotCJFv0BljlDWdlN3Js_gUXZSyI5N1QoglfYdOOWmJkoSfod_XAWrjYA_RQazYj9HWkCJOHtctYLiv2Vjo-7E3GQ-m5nCP9zlVSJv-YE3Eq3EIsw_TzBpKqAdsosObfrSpAN6mAVKppoTyHr31pi9w8eDP0a9vX39e3TSrH99vr76sGtsKXhtOl9K21Bnp7ZJ1nEtCWr-20oGwUlDHu0450lrpnfKSW2UVCKXkWilPieTn6PMRdz-uB3B2uiubXu9zGEw-6GSCflmJYas36U4LzjhVdAL49ACQ058RStVDKPMTTIQ0Fs0oZ0yKjrCptT222pxKyeAfaSjRs1R6p49S6VmqOUv-rfjx-YqPQ_-FeboBpkfdBci62ADRggsZbNUuhdcZ_gJJkKom</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Wolff, G.</creator><creator>Taranko, A.E.</creator><creator>Meln, I.</creator><creator>Weinmann, J.</creator><creator>Sijmonsma, T.</creator><creator>Lerch, S.</creator><creator>Heide, D.</creator><creator>Billeter, A.T.</creator><creator>Tews, D.</creator><creator>Krunic, D.</creator><creator>Fischer-Posovszky, P.</creator><creator>Müller-Stich, B.P.</creator><creator>Herzig, S.</creator><creator>Grimm, D.</creator><creator>Heikenwälder, M.</creator><creator>Kao, W.W.</creator><creator>Vegiopoulos, A.</creator><general>Elsevier GmbH</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190101</creationdate><title>Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis</title><author>Wolff, G. ; Taranko, A.E. ; Meln, I. ; Weinmann, J. ; Sijmonsma, T. ; Lerch, S. ; Heide, D. ; Billeter, A.T. ; Tews, D. ; Krunic, D. ; Fischer-Posovszky, P. ; Müller-Stich, B.P. ; Herzig, S. ; Grimm, D. ; Heikenwälder, M. ; Kao, W.W. ; Vegiopoulos, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-3157c41da7fc528337004fbc7de6c761d3889d04c7fd9f73c9c9e6997b99f1073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adipocytes - metabolism</topic><topic>Adipose</topic><topic>Adipose Tissue - metabolism</topic><topic>Adipose Tissue, White - metabolism</topic><topic>Adiposity - drug effects</topic><topic>Adult</topic><topic>Animals</topic><topic>Brief Communication</topic><topic>Diet, High-Fat</topic><topic>ECM</topic><topic>Extracellular Matrix - metabolism</topic><topic>Female</topic><topic>Glucose - metabolism</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Intra-Abdominal Fat - metabolism</topic><topic>Liver - metabolism</topic><topic>Lumican</topic><topic>Lumican - genetics</topic><topic>Lumican - metabolism</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Middle Aged</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Obesity</topic><topic>Obesity - metabolism</topic><topic>Proteoglycans - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolff, G.</creatorcontrib><creatorcontrib>Taranko, A.E.</creatorcontrib><creatorcontrib>Meln, I.</creatorcontrib><creatorcontrib>Weinmann, J.</creatorcontrib><creatorcontrib>Sijmonsma, T.</creatorcontrib><creatorcontrib>Lerch, S.</creatorcontrib><creatorcontrib>Heide, D.</creatorcontrib><creatorcontrib>Billeter, A.T.</creatorcontrib><creatorcontrib>Tews, D.</creatorcontrib><creatorcontrib>Krunic, D.</creatorcontrib><creatorcontrib>Fischer-Posovszky, P.</creatorcontrib><creatorcontrib>Müller-Stich, B.P.</creatorcontrib><creatorcontrib>Herzig, S.</creatorcontrib><creatorcontrib>Grimm, D.</creatorcontrib><creatorcontrib>Heikenwälder, M.</creatorcontrib><creatorcontrib>Kao, W.W.</creatorcontrib><creatorcontrib>Vegiopoulos, A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular metabolism (Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolff, G.</au><au>Taranko, A.E.</au><au>Meln, I.</au><au>Weinmann, J.</au><au>Sijmonsma, T.</au><au>Lerch, S.</au><au>Heide, D.</au><au>Billeter, A.T.</au><au>Tews, D.</au><au>Krunic, D.</au><au>Fischer-Posovszky, P.</au><au>Müller-Stich, B.P.</au><au>Herzig, S.</au><au>Grimm, D.</au><au>Heikenwälder, M.</au><au>Kao, W.W.</au><au>Vegiopoulos, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis</atitle><jtitle>Molecular metabolism (Germany)</jtitle><addtitle>Mol Metab</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>19</volume><spage>97</spage><epage>106</epage><pages>97-106</pages><issn>2212-8778</issn><eissn>2212-8778</eissn><abstract>Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan Lumican in metabolically driven nonalcoholic fatty liver disease sparks an interest in further understanding its role in diet-induced obesity and metabolic complications.
Whole body ablation of Lumican (Lum−/−) gene and adeno-associated virus-mediated over-expression were used in combination with control or high fat diet to assess energy balance, glucose homeostasis as well as adipose tissue health and remodeling.
Lumican was found to be particularly enriched in the stromal cells isolated from murine gonadal white adipose tissue. Likewise murine and human visceral fat showed a robust increase in Lumican as compared to fat from the subcutaneous depot. Lumican null female mice exhibited moderately increased fat mass, decreased insulin sensitivity and increased liver triglycerides in a diet-dependent manner. These changes coincided with inflammation in adipose tissue and no overt effects in adipose expandability, i.e. adipocyte formation and hypertrophy. Lumican over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.
These data indicate that Lumican may represent a functional link between the extracellular matrix, glucose homeostasis, and features of the metabolic syndrome.
•The extracellular matrix proteoglycan Lumican (Lum) is particularly enriched in stromal cells within white adipose tissue.•Visceral fat from obese patients displays increased levels of Lum compared to subcutaneous fat.•Lum-Ko female mice exhibit decreased insulin sensitivity and increased triglycerides upon high-fat diet (HFD) feeding.•Lum-Ko female mice on HFD have increased inflammation in white fat in the absence of overt effects on adipocyte formation.•· Lum over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>30409703</pmid><doi>10.1016/j.molmet.2018.10.007</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2212-8778 |
ispartof | Molecular metabolism (Germany), 2019-01, Vol.19, p.97-106 |
issn | 2212-8778 2212-8778 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6323191 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adipocytes - metabolism Adipose Adipose Tissue - metabolism Adipose Tissue, White - metabolism Adiposity - drug effects Adult Animals Brief Communication Diet, High-Fat ECM Extracellular Matrix - metabolism Female Glucose - metabolism Homeostasis Humans Inflammation Insulin Insulin Resistance Intra-Abdominal Fat - metabolism Liver - metabolism Lumican Lumican - genetics Lumican - metabolism Male Mice Mice, Inbred C57BL Mice, Knockout Middle Aged Non-alcoholic Fatty Liver Disease - metabolism Obesity Obesity - metabolism Proteoglycans - metabolism |
title | Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A13%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diet-dependent%20function%20of%20the%20extracellular%20matrix%20proteoglycan%20Lumican%20in%20obesity%20and%20glucose%20homeostasis&rft.jtitle=Molecular%20metabolism%20(Germany)&rft.au=Wolff,%20G.&rft.date=2019-01-01&rft.volume=19&rft.spage=97&rft.epage=106&rft.pages=97-106&rft.issn=2212-8778&rft.eissn=2212-8778&rft_id=info:doi/10.1016/j.molmet.2018.10.007&rft_dat=%3Cproquest_pubme%3E2132276802%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2132276802&rft_id=info:pmid/30409703&rft_els_id=S2212877818308378&rfr_iscdi=true |